Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iwona Dankiewicz-Fares

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Reumatologia|November 16, 2023
Ocular involvement in rheumatic diseasesIwona Dankiewicz-Fares, Daniel Jeka, Tacjana Barczyńska
Annales Academiae Medicae Stetinensis|February 7, 2013
[Atypical location of Wegener's granulomatosis with breast involvement: case report]Tacjana Barczyńska, Iwona Dankiewicz-Fares, Halina Bilińska-Reszkowska, et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|March 21, 2018
Efficacy and safety of golimumab as add-on therapy to standard disease-modifying antirheumatic drugs: Results of the GO-MORE study in the Polish populationSławomir Jeka, Bogdan Batko, Mariusz Korkosz, et al.
Reumatologia|May 28, 2019
Determination of antibodies in everyday rheumatological practiceKatarzyna Napiórkowska-Baran, Joanna Zalewska, Sławomir Jeka, et al.
Lupus Science & Medicine|June 17, 2026
Phase Ib, multicentre, open-label, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of subcutaneously administered mosunetuzumab in participants with systemic lupus erythematosusElsa Martins, Vishala L Chindalore, X Rebecca Sheng, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Reumatologia|November 16, 2023
Ocular involvement in rheumatic diseasesIwona Dankiewicz-Fares, Daniel Jeka, Tacjana Barczyńska
Annales Academiae Medicae Stetinensis|February 7, 2013
[Atypical location of Wegener's granulomatosis with breast involvement: case report]Tacjana Barczyńska, Iwona Dankiewicz-Fares, Halina Bilińska-Reszkowska, et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|March 21, 2018
Efficacy and safety of golimumab as add-on therapy to standard disease-modifying antirheumatic drugs: Results of the GO-MORE study in the Polish populationSławomir Jeka, Bogdan Batko, Mariusz Korkosz, et al.
Reumatologia|May 28, 2019
Determination of antibodies in everyday rheumatological practiceKatarzyna Napiórkowska-Baran, Joanna Zalewska, Sławomir Jeka, et al.
Lupus Science & Medicine|June 17, 2026
Phase Ib, multicentre, open-label, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of subcutaneously administered mosunetuzumab in participants with systemic lupus erythematosusElsa Martins, Vishala L Chindalore, X Rebecca Sheng, et al.
Pageof 1